EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome

M Stayoussef, X Weili, A Habel, M Barbirou, S Bedoui, A Attia, Y Omrani, K Zouari, H Maghrebi, W Y Almawi, B Bouhaouala-Zahar, A Larbi und 1 weitere

Cancer Immunology, Immunotherapy · 02.07.2024 · 73 (9)

DOI: 10.1007/s00262-024-03746-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 02.07.2024. Verfasst von M Stayoussef und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mycology, Faculty of Sciences of Tunis (FST), Pathologies and Biomarkers (LR16ES05), University of Tunis El Manar (UTM), 1092, Tunis, T…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cytokines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency for Science Technology and Research, Tunisia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insofar as they play an important role in the pathogenesis of colorectal cancer (CRC), this study analyzes the serum profile of cytokines, chemokines, growth factors, and soluble receptors in patients with CRC and cancer-free controls as possible CRC signatures. Serum levels of 65 analytes were measured in patients with CRC and age- and sex-matched cancer-free controls using the ProcartaPlex Human Immune Monitoring 65-Plex Panel. Of the 65 tested analytes, 8 cytokines (CSF-3, IFN-γ, IL-12p70, IL-18, IL-20, MIF, TNF-α and TSLP), 8 chemokines (fractalkine, MIP-1β, BLC, Eotaxin-1, Eotaxin-2, IP-10, MIP-1a, MIP-3a), 2 growth factors (FGF-2, MMP-1), and 4 soluble receptors (APRIL, CD30, TNFRII, and TWEAK), were differentially expressed in CRC. ROC analysis confirmed the high association of TNF-α, BLC, Eotaxin-1, APRIL, and Tweak with AUC > 0.70, suggesting theranostic application. The expression of IFN-γ, IL-18, MIF, BLC, Eotaxin-1, Eotaxin-2, IP-10, and MMP1 was lower in metastatic compared to non-metastatic CRC; only AUC of MIF and MIP-1β were > 0.7. Moreover, MDC, IL-7, MIF, IL-21, and TNF-α are positively associated with tolerance to CRC chemotherapy (CT) (AUC > 0.7), whereas IL-31, Fractalkine, Eotaxin-1, and Eotaxin-2 were positively associated with resistance to CT. TNF-α, BLC, Eotaxin-1, APRIL, and Tweak may be used as first-line early detection of CRC. The variable levels of MIF and MIP-1β between metastatic and non-metastatic cases assign prognostic nature to these factors in CRC progression. Regarding tolerance to CT, MDC, IL-7, MIF, IL-21, and TNF-α are key when down-regulated or resistant to treatment is observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCytokinesHumansFemaleMaleMiddle AgedAgedIntercellular Signaling Peptides and ProteinsChemokinesTreatment OutcomeBiomarkers, TumorAdultPrognosisCase-Control Studies

Stichwörter der Autor:innen

Biomarker discoveryChemokinesChemoresistanceColorectal cancerCytokinesMetastasis

Substanzen

CytokinesIntercellular Signaling Peptides and ProteinsChemokinesBiomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Mycology, Faculty of Sciences of Tunis (FST), Pathologies and Biomarkers (LR16ES05), University of Tunis El Manar (UTM), 1092, Tunis, Tunisia. mounawww@yahoo.fr.
  • Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, Singapore, 138648, Singapore.
  • Laboratory of Mycology, Faculty of Sciences of Tunis (FST), Pathologies and Biomarkers (LR16ES05), University of Tunis El Manar (UTM), 1092, Tunis, Tunisia.
  • Center for Biomedical Informatics, University of Missouri School of Medicine, Columbia, MO, USA.
  • Laboratory of Biomolecules, Venoms and Theranostic Applications, University of Tunis El Manar (UTM), Pasteur Institute of Tunis, 13 Place Pasteur, B.P. 74, 1002, Tunis, Tunisia.
  • Department of Digestive Surgery, Fattouma Bourguiba Hospital, University of Monastir, Monastir, Tunisia.

Förderung

  • Agency for Science Technology and Research, Tunisia

Zitieren

APA

Stayoussef, M., Weili, X., Habel, A., Barbirou, M., Bedoui, S., Attia, A., Omrani, Y., Zouari, K., Maghrebi, H., Almawi, W. Y., Bouhaouala-Zahar, B., Larbi, A., & Yacoubi-Loueslati, B. (2024). Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome. Cancer Immunology, Immunotherapy, 73(9). https://doi.org/10.1007/s00262-024-03746-x

Vancouver

Stayoussef M, Weili X, Habel A, Barbirou M, Bedoui S, Attia A, et al. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome. Cancer Immunology, Immunotherapy. 2024;73(9). doi:10.1007/s00262-024-03746-x

BibTeX
@article{Stayoussef2024,
  author = {Stayoussef, M and Weili, X and Habel, A and Barbirou, M and Bedoui, S and Attia, A and Omrani, Y and Zouari, K and Maghrebi, H and Almawi, W Y and Bouhaouala-Zahar, B and Larbi, A and Yacoubi-Loueslati, B},
  title = {Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  volume = {73},
  number = {9},
  doi = {10.1007/s00262-024-03746-x}
}
Kostenlos starten →